Fri, 04 Jul 2008 18:25:10 GMT
‘Dr Reddy’s will clock 25% growth this year’ (The Hindu)
Hyderabad, July 4 Pharma major Dr Reddy’s Laboratories is upbeat on its performance this year in view of the revenues from upsides and possible higher profits from its German arm, Betapharm. | Fri, 04 Jul 2008 18:18:17 GMT
Markets (July 04) (The Hindu)
ANNOUNCEMENTS DuPont launches two herbicides Chennai, July 4 E.I. DuPont India Pvt Ltd has launched two herbicides for rice and sugarcane crops. These will be followed up with the launch of a range of crop protection chemicals including Rynaxypyr, a broad spectrum insecticide that ... | Thu, 19 Jun 2008 18:38:02 GMT
Dr Reddys Laboratories (Rs 680.20): Sell (The Hindu)
We recommend a sell in Dr Reddys Laboratories from a short-term perspective. The stock has been on a medium-term uptrend since its February 2008 low of Rs 501. However, the stock met with a significant resistance at Rs 720 level in early June and gradually began to move sideways. | Sat, 07 Jun 2008 19:33:46 GMT
Dr Reddy’s seeks declaratory verdict on Nexium in US (The Hindu)
Hyderabad, June 7 In pursuance of its ongoing litigation on cardio drug Nexium (Esomeprazole), pharma major Dr Reddy’s Laboratories Ltd filed for a declaratory judgment on its patents in a US court. | Thu, 19 Jun 2008 18:37:02 GMT
The importance of being Lipitor (The Hindu)
Intellectual property-related battles aside, the importance of a Lipitor is its relevance to patients. Generic copies of innovative drugs are more accessible to consumers as they are usually sold at a lower price. | Wed, 18 Jun 2008 16:51:42 GMT
Ranbaxy CEO sees consolidation wave over 3 years (Reuters via Yahoo! India News)
By Michael Kahn | Thu, 12 Jun 2008 11:39:45 GMT
Ranbaxy drug buy a sign India predators may now be prey (Reuters via Yahoo! India News)
By Hiral Vora and Bharghavi Nagaraju |
|
|
|
Thu, 12 Jun 2008 11:14:49 GMT
| Wed, 18 Jun 2008 15:03:50 GMT
| Wed, 11 Jun 2008 11:52:46 GMT
| Thu, 12 Jun 2008 03:31:10 GMT
|
|
|
